MedTrace Logo

Atropine for Preventing Ventilator-Associated Pneumonia

NCT02704923 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-03-10

No results posted yet for this study

Summary

A double-blind, placebo controlled trial of atropine eye drops used by sublingual way for preventing Ventilator-Associated Pneumonia.

Conditions

  • Ventilator-Associated Pneumonia

Interventions

DRUG

Atropine

Atropine eye drops (1%) administered by sublingual way (2 drops) every 6 hours

DRUG

Placebo

Placebo eye drops characterized by saline administered by sublingual way (2 drops) every 6 hours

Sponsors & Collaborators

  • Universidade de Passo Fundo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02704923 on ClinicalTrials.gov